Suppr超能文献

间皮瘤和胸膜斑患者与暴露于环境石棉的健康个体血清生化标志物的比较。

Comparison of serum biochemical markers in patients with mesothelioma and pleural plaques versus healthy individuals exposed to environmental asbestos.

作者信息

Döngel İsa, Akbaş Ali, Benli İsmail, Bayram Mehmet

机构信息

Department of Thoracic Surgery, Süleyman Demirel University Medical Faculty, Isparta, Turkey.

Department of Clinical Biochemistry, Ataturk State Hospital, Balıkesir, Turkey.

出版信息

Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Jun 28;27(3):374-380. doi: 10.5606/tgkdc.dergisi.2019.17557. eCollection 2019 Jul.

Abstract

BACKGROUND

In this study, we aimed to compare serum biochemical markers in patients with malignant pleural mesothelioma and pleural plaques versus healthy individuals exposed to environmental asbestos.

METHODS

Between September 01, 2010 and March 31, 2011, a total of 540 participants (354 males, 186 females; mean age 61.4 years; range, 35 to 89 years) were included in the study. The participants were divided into four groups as follows: (1) patients with pleural plaques (n=277); (2) healthy individuals with normal chest X-rays who were exposed to environmental asbestos (n=121); (3) healthy individuals with normal chest X-rays who were not exposed to environmental asbestos (n=118); and (4) patients with malignant pleural mesothelioma (n=24). Serum levels of carcinoembryonic antigen, cancer antigen 125, 15-3, 19-9, free T3, free T4, thyroidstimulating hormone, vitamin B12, folate, and ferritin were measured.

RESULTS

Serum cancer antigen 125, 15-3, folic acid, vitamin B12, and ferritin levels were higher with lower free T3 levels in Group 4 than the other groups. The areas under the curve for cancer antigen 125 and 15-3 were 0.78 and 0.67, respectively in the differential diagnosis of mesothelioma from other pathologies (p<0.001 for both). Optimal limits of these biomarkers were 13.63 and 18.43 ng/mL, respectively with 83% and 75% sensitivity and 69% and 48% specificity, respectively.

CONCLUSION

The combination or individual use of serum cancer antigen 125, 15-3, folic acid, vitamin B12, and ferritin levels may be helpful for early diagnosis and treatment of malignant pleural mesothelioma.

摘要

背景

在本研究中,我们旨在比较恶性胸膜间皮瘤患者、胸膜斑患者与暴露于环境石棉的健康个体的血清生化标志物。

方法

2010年9月1日至2011年3月31日期间,共有540名参与者(354名男性,186名女性;平均年龄61.4岁;范围35至89岁)纳入本研究。参与者被分为以下四组:(1)胸膜斑患者(n = 277);(2)胸部X线正常且暴露于环境石棉的健康个体(n = 121);(3)胸部X线正常且未暴露于环境石棉的健康个体(n = 118);(4)恶性胸膜间皮瘤患者(n = 24)。检测血清癌胚抗原、癌抗原125、15 - 3、19 - 9、游离T3、游离T4、促甲状腺激素、维生素B12、叶酸和铁蛋白水平。

结果

第4组血清癌抗原125、15 - 3、叶酸、维生素B12和铁蛋白水平较高,游离T3水平较低,高于其他组。在间皮瘤与其他病理情况的鉴别诊断中,癌抗原125和15 - 3的曲线下面积分别为0.78和0.67(两者p均<0.001)。这些生物标志物的最佳界限分别为13.63和18.43 ng/mL,敏感性分别为83%和75%,特异性分别为69%和48%。

结论

血清癌抗原125、15 - 3、叶酸、维生素B12和铁蛋白水平的联合或单独使用可能有助于恶性胸膜间皮瘤的早期诊断和治疗。

相似文献

1
Comparison of serum biochemical markers in patients with mesothelioma and pleural plaques versus healthy individuals exposed to environmental asbestos.
Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Jun 28;27(3):374-380. doi: 10.5606/tgkdc.dergisi.2019.17557. eCollection 2019 Jul.
3
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.
N Engl J Med. 2005 Oct 13;353(15):1564-73. doi: 10.1056/NEJMoa051185.
6
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.
N Engl J Med. 2012 Oct 11;367(15):1417-27. doi: 10.1056/NEJMoa1115050.
7
Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Sep;159(3):472-9. doi: 10.5507/bp.2014.015. Epub 2014 Apr 29.
8
Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.
Eur J Cardiothorac Surg. 2013 May;43(5):940-5. doi: 10.1093/ejcts/ezs521. Epub 2012 Oct 7.
9
Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study.
Cancer Sci. 2015 Jul;106(7):825-32. doi: 10.1111/cas.12687. Epub 2015 Jun 5.
10
Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):646-50. doi: 10.1158/1055-9965.EPI-08-0422. Epub 2009 Feb 3.

引用本文的文献

1
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis.
Eur Respir Rev. 2021 Nov 17;30(162). doi: 10.1183/16000617.0057-2021. Print 2021 Dec 31.
2
Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.
Cancers (Basel). 2021 Feb 6;13(4):658. doi: 10.3390/cancers13040658.

本文引用的文献

2
Tenascin XB Is a Novel Diagnostic Marker for Malignant Mesothelioma.
Anticancer Res. 2019 Feb;39(2):627-633. doi: 10.21873/anticanres.13156.
4
Serum mesothelin and other biomarkers: what have we learned in the last decade?
J Thorac Dis. 2018 Jan;10(Suppl 2):S353-S359. doi: 10.21037/jtd.2017.10.132.
5
Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: A preliminary study.
Eur J Surg Oncol. 2018 Jun;44(6):792-798. doi: 10.1016/j.ejso.2018.02.010. Epub 2018 Feb 17.
6
Elevated Serum Vitamin B Levels as a Prognostic Factor for Survival Time in Metastatic Cancer Patients: A Retrospective Study.
Nutr Cancer. 2018 Jan;70(1):37-44. doi: 10.1080/01635581.2018.1397711. Epub 2017 Dec 8.
7
A Novel Panel of Serum Biomarkers for MPM Diagnosis.
Dis Markers. 2017;2017:3510984. doi: 10.1155/2017/3510984. Epub 2017 Feb 28.
8
Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.
Br J Cancer. 2017 Mar 14;116(6):731-741. doi: 10.1038/bjc.2017.22. Epub 2017 Feb 7.
10
Oxidative status and acute phase reactants in patients with environmental asbestos exposure and mesothelioma.
ScientificWorldJournal. 2014 Jan 23;2014:902748. doi: 10.1155/2014/902748. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验